x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Kock, RichardRemove Kock, Richard filter
Publication Date
Please choose a date range between 2020 and 2021.
Author
- Ntoumi, Francine5
- Petersen, Eskild4
- Zumla, Alimuddin4
- Hui, David S3
- Ippolito, Giuseppe3
- Kapata, Nathan3
- Asogun, Danny2
- Azhar, Esam I2
- Bates, Matthew2
- Blumberg, Lucille2
- Dar, Osman2
- Drosten, Christian2
- Edwards, Sarah2
- Haider, Najmul2
- Hamer, Davidson H2
- Memish, Ziad A2
- Abdel Hamid, Muzamil Mahdi1
- Abubakar, Aisha1
- Akipede, George O1
- Aklillu, Eleni1
- Al-Abri, Seif1
- Ansumana, Rashid1
- Arruda, Liã Bárbara1
- Azhar, Esam Ibraheem1
Coronavirus (COVID-19) Collection
6 Results
- EditorialOpen Access
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
International Journal of Infectious DiseasesVol. 114p268–272Published online: December 1, 2021- Eskild Petersen
- Francine Ntoumi
- David S Hui
- Aisha Abubakar
- Laura D. Kramer
- Christina Obiero
- and others
Cited in Scopus: 100Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b). The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible. - EditorialOpen Access
Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa
International Journal of Infectious DiseasesVol. 96p308–310Published online: May 10, 2020- Leonard E.G. Mboera
- George O. Akipede
- Amitava Banerjee
- Luis E. Cuevas
- Thomas Czypionka
- Mishal Khan
- Richard Kock
- David McCoy
- Blandina T. Mmbaga
- Gerald Misinzo
- Elizabeth H. Shayo
- Meru Sheel
- Calvin Sindato
- Mark Urassa
Cited in Scopus: 28The coronavirus disease 2019 (COVID-19) which was first reported in Wuhan, China at the end of 2019 (Luo et al., 2020) has spread across the world with remarkable speed, with the World Health Organization (WHO) officially declaring a pandemic in March, 2020. Most countries in sub-Saharan Africa (SSA) are now reporting an increasing number of cases, both imported and acquired locally. As of April 14th, 2020, a cumulative total of approximately, 10,757 confirmed COVID-19 cases with 520 deaths have been reported within the WHO African Region, with South Africa, Algeria and Cameroon recording the highest number of cases (WHO, 2020a). - EditorialOpen Access
COVID-19 travel restrictions and the International Health Regulations – Call for an open debate on easing of travel restrictions
International Journal of Infectious DiseasesVol. 94p88–90Published online: April 16, 2020- Eskild Petersen
- Brian McCloskey
- David S. Hui
- Richard Kock
- Francine Ntoumi
- Ziad A. Memish
- Nathan Kapata
- Esam I. Azhar
- Marjorie Pollack
- Larry C. Madoff
- Davidson H. Hamer
- Jean B. Nachega
- N. Pshenichnaya
- Alimuddin Zumla
Cited in Scopus: 24The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) has made national governments worldwide to mandate several generic infection control measures such as physical distancing, self-isolation, and closure of non-essential shops, restaurants schools, among others. Some models suggest physical distancing would have to persist for 3 months to mitigate the peak effects on health systems and could be required on an intermittent basis for 12 to 18 months (Flaxman et al., 2020). - EditorialOpen Access
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
International Journal of Infectious DiseasesVol. 93p205–207Published online: March 3, 2020- Eskild Petersen
- David Hui
- Davidson H. Hamer
- Lucille Blumberg
- Lawrence C. Madoff
- Marjorie Pollack
- Shui Shan Lee
- Susan McLellan
- Ziad Memish
- Ira Praharaj
- Sean Wasserman
- Francine Ntoumi
- Esam Ibraheem Azhar
- Timothy D. Mchugh
- Richard Kock
- Guiseppe Ippolito
- Ali Zumla
- Marion Koopmans
Cited in Scopus: 48Dr Li Wenliang, who lost his life to the novel coronavirus, SARS-CoV-2, became the face of the threat of SARS-CoV-2 to frontline workers, the clinicians taking care of patients. Li, 34, was an ophthalmologist at Wuhan Central Hospital. On 30th December, 2019, when the Wuhan municipal health service sent out an alert, he reportedly warned a closed group of ex-medical school classmates on the WeChat social media site of “Seven cases of severe acute respiratory syndrome (SARS) like illness with links with the Huanan Seafood Wholesale Market” at his hospital. - EditorialOpen Access
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future
International Journal of Infectious DiseasesVol. 93p233–236Published online: February 28, 2020- Nathan Kapata
- Chikwe Ihekweazu
- Francine Ntoumi
- Tajudeen Raji
- Pascalina Chanda-Kapata
- Peter Mwaba
- Victor Mukonka
- Matthew Bates
- John Tembo
- Victor Corman
- Sayoki Mfinanga
- Danny Asogun
- Linzy Elton
- Liã Bárbara Arruda
- Margaret J. Thomason
- Leonard Mboera
- Alexei Yavlinsky
- Najmul Haider
- David Simons
- Lara Hollmann
- Swaib A. Lule
- Francisco Veas
- Muzamil Mahdi Abdel Hamid
- Osman Dar
- Sarah Edwards
- Francesco Vairo
- Timothy D. McHugh
- Christian Drosten
- Richard Kock
- Giuseppe Ippolito
- Alimuddin Zumla
Cited in Scopus: 113Soon after the novel coronavirus, SARS-CoV-2 (2019-nCoV), was first identified in a cluster of patients with pneumonia (Li et al., 2020), in the Chinese city of Wuhan on 31 December 2019, rapid human to human transmission was anticipated (Hui et al., 2020). The fast pace of transmission is wreaking havoc and stirring media hype and public health concern (Ippolito et al., 2020) globally. When the World Health Organization (WHO) declared the disease, (now officially named COVID-19) a Public Health Emergency of International Concern (PHEIC) on 31st January 2020 (WHO, 2020a), the Director General Dr Tedros Ghebreyesus justified the decision by stating that WHOs greatest concern was the potential for the virus to spread to countries with weaker health systems. - EditorialOpen Access
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
International Journal of Infectious DiseasesVol. 91p264–266Published online: January 14, 2020- David S. Hui
- Esam I Azhar
- Tariq A. Madani
- Francine Ntoumi
- Richard Kock
- Osman Dar
- Giuseppe Ippolito
- Timothy D. Mchugh
- Ziad A. Memish
- Christian Drosten
- Alimuddin Zumla
- Eskild Petersen
Cited in Scopus: 2077The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak of pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link to the Huanan Seafood Wholesale Market where there was also sale of live animals. Notification of the WHO on 31 Dec 2019 by the Chinese Health Authorities has prompted health authorities in Hong Kong, Macau, and Taiwan to step up border surveillance, and generated concern and fears that it could mark the emergence of a novel and serious threat to public health (WHO, 2020a; Parr, 2020).
